Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 BMC Pediatr
11 BMJ
3 Epidemiol Infect
1 J Exp Med
1 J Gen Virol
1 J Immunol
24 J Infect
1 J Virol
1 J Virol Methods
4 Lancet
1 N Engl J Med
1 PLoS Biol
2 PLoS Comput Biol
1 PLoS Genet
40 PLoS One
5 Proc Natl Acad Sci U S A
9 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Pediatr

  1. BAKALLI I, Biqiku M, Cela D, Demrozi A, et al
    Atraumatic splenic rupture in a child with COVID 19.
    BMC Pediatr. 2022;22:300.
    PubMed         Abstract available


  2. WISE J
    Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds.
    BMJ. 2022;377:o1305.

    Helen Salisbury: Living under the long shadow of covid.
    BMJ. 2022;377:o1288.

  4. GAZIT S, Saciuk Y, Perez G, Peretz A, et al
    Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.
    BMJ. 2022;377:e071113.
    PubMed         Abstract available

  5. LIMB M
    Covid-19: Doctors' wellbeing must be "critical priority" after pandemic mistakes, says BMA.
    BMJ. 2022;377:o1284.

  6. HORDIJK L, Patnaik P
    Covid-19-How Europe's vaccine donations went tragically wrong.
    BMJ. 2022;377:o1286.

    Covid-19: Sexually transmitted diseases surged in US during pandemic.
    BMJ. 2022;377:o1275.

  8. WISE J
    Covid-19: JCVI advises further booster for vulnerable adults and health and care workers.
    BMJ. 2022;377:o1277.

    Covid-19: Second boosters may benefit at-risk groups but have "minimal" impact for others, says WHO.
    BMJ. 2022;377:o1259.

    Covid-19: Government failed to protect doctors during pandemic, BMA inquiry finds.
    BMJ. 2022;377:o1235.

  11. Caught on film: NHS life during the pandemic.
    BMJ. 2022;377:o1224.

  12. TANNE JH
    Covid-19: US hospitals continued to perform unnecessary surgeries during pandemic.
    BMJ. 2022;377:o1254.

    Epidemiol Infect

  13. WONG JY, Cheung CM, Bond HS, Cheung JK, et al
    Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019.
    Epidemiol Infect. 2022;150:e101.
    PubMed         Abstract available

  14. SHINGLETON J, Finnie T, Gent N, Bennett E, et al
    Assessing the role of imported cases on the establishment of SARS-CoV-2 Delta variant of concern in Bolton, UK.
    Epidemiol Infect. 2022;150:e100.
    PubMed         Abstract available

  15. HIIRONEN I, Saavedra-Campos M, Panitz J, Ma T, et al
    Workplace exposures associated with COVID-19: evidence from a case-control study with multiple sampling periods in England, August-October 2020.
    Epidemiol Infect. 2022;150:e99.
    PubMed         Abstract available

    J Exp Med

  16. WARE CF, Croft M, Neil GA
    Realigning the LIGHT signaling network to control dysregulated inflammation.
    J Exp Med. 2022;219.
    PubMed         Abstract available

    J Gen Virol

  17. DE MOOR WRJ, Regnard GL, Rybicki EP, Williamson AL, et al
    Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus.
    J Gen Virol. 2022;103.
    PubMed         Abstract available

    J Immunol

  18. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    PubMed         Abstract available

    J Infect

  19. LI Y, Wei L, He L, Sun J, et al
    Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
    PubMed         Abstract available

  20. WHITAKER H, Tsang RS, Button E, Andrews N, et al
    Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
    PubMed         Abstract available

  21. LIU X, Munro APS, Feng S, Janani L, et al
    Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
    PubMed         Abstract available

  22. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.

  23. BADDAL B, Bostanci A
    The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.

  24. CHENG CY, Hsiao SH, Fang TC, Lin YC, et al
    SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.

  25. YOON JG, Yoo JS, Lee J, Hyun HJ, et al
    Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
    J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.

  26. MENG J, Ge Q, Li J, Lu X, et al
    Protective trend of anti-androgen therapy during the COVID-19 pandemic: a meta-analysis.
    J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.

  27. SCHILDGEN V, Lusebrink J, Schildgen O
    Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnarable individuals.
    J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.

  28. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
    J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.

  29. MURGIA F, Fiamma M, Serra S, Olla S, et al
    The impact of secondary infections in COVID-19 critically ill patients.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.

  30. DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al
    Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.
    J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.

  31. AO G, Wang Y, Li A, Tran C, et al
    The effect of canakinumab on clinical outcomes in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.

  32. CHEN C, Tang J, Wang C, Wen W, et al
    Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients Discharged.
    J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.

  33. FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al
    Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.

  34. GIMENEZ E, Albert E, Burgos JS, Peiro S, et al
    SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
    PubMed         Abstract available

  35. BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al
    SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.

  36. SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr
    Effectiveness of COVID-19 vaccines in Qatar.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.

  37. HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al
    Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or ChAdOx1 and Heterologous Third Dose with BNT162b2.
    J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.

  38. KONIG S, Hohenstein S, Leiner J, Hindricks G, et al
    National mortality data for Germany before and throughout the pandemic: there is an excess mortality exceeding COVID-19-attributed fatalities.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.

  39. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.

  40. SAEED A, Ahmad B, Majaz S, Nouroz F, et al
    Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of Main Protease 3CL Mpro: Molecular Simulation Analysis.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.

  41. ZHENG J, Wang Z, Li J, Zhang Y, et al
    High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.

  42. KWOK KO, Wei WI, Ma BHM, Ip M, et al
    Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.

    J Virol

  43. ZHENG H, Ma L, Gui R, Lin X, et al
    G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2.
    J Virol. 2022 May 23:e0049422. doi: 10.1128/jvi.00494.
    PubMed         Abstract available

    J Virol Methods

  44. DE OLIVEIRA PSS, de Oliveira Silva B, E Silva RP, Galdino LV, et al
    Evaluation of long-term stability of SARS-CoV-2 nucleic acid extracted from human nasopharyngeal samples.
    J Virol Methods. 2022;305:114529.
    PubMed         Abstract available


  45. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.

  46. PEREZ-FERNANDEZ XL, Fuset-Cabanes M, Hernandez-Platero L
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
    JAMA. 2022;327:2022-2023.

  47. YARNELL CJ, Sklar MC
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
    JAMA. 2022;327:2023.

  48. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.

  49. COUPER K, Connolly BA, McAuley DF
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.
    JAMA. 2022;327:2023-2024.

  50. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.

  51. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
    Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
    PubMed         Abstract available

  52. TSAY SV, Bartoces M, Gouin K, Kabbani S, et al
    Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021.
    JAMA. 2022 Apr 8. pii: 2791077. doi: 10.1001/jama.2022.5471.

  53. BRADLEY MC, Perez-Vilar S, Chillarige Y, Dong D, et al
    Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.
    JAMA. 2022 Apr 8. pii: 2791078. doi: 10.1001/jama.2022.4877.


  54. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.

  55. HORTON R
    Offline: How to fix pandemic preparedness.
    Lancet. 2022;399:1927.

  56. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.

  57. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    PubMed         Abstract available

    N Engl J Med

  58. HALL VG, Ferreira VH, Ku T, Ierullo M, et al
    Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.

    PLoS Biol

  59. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
    PLoS Biol. 2022;20:e3001506.
    PubMed         Abstract available

    PLoS Comput Biol

  60. RAHMANDAD H, Xu R, Ghaffarzadegan N
    Enhancing long-term forecasting: Learning from COVID-19 models.
    PLoS Comput Biol. 2022;18:e1010100.
    PubMed         Abstract available

  61. RIBEIRO-FILHO HV, Jara GE, Batista FAH, Schleder GR, et al
    Structural dynamics of SARS-CoV-2 nucleocapsid protein induced by RNA binding.
    PLoS Comput Biol. 2022;18:e1010121.
    PubMed         Abstract available

    PLoS Genet

  62. WARMERDAM CAR, Wiersma HH, Lanting P, Ani A, et al
    Increased genetic contribution to wellbeing during the COVID-19 pandemic.
    PLoS Genet. 2022;18:e1010135.
    PubMed         Abstract available

    PLoS One

  63. GOMEZ-ROAS MV, Davis KM, Leziak K, Jackson J, et al
    Postpartum during a pandemic: Challenges of low-income individuals with healthcare interactions during COVID-19.
    PLoS One. 2022;17:e0268698.
    PubMed         Abstract available

  64. TENG IT, Nazzari AF, Choe M, Liu T, et al
    Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.
    PLoS One. 2022;17:e0268767.
    PubMed         Abstract available

  65. SPRENGHOLZ P, Henkel L, Betsch C
    Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in Germany.
    PLoS One. 2022;17:e0268911.
    PubMed         Abstract available

  66. NUNES DR, Braconi CT, Ludwig-Begall LF, Arns CW, et al
    Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution.
    PLoS One. 2022;17:e0268389.
    PubMed         Abstract available

  67. SILVA EKVB, Bomfim CG, Barbosa AP, Noda P, et al
    Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.
    PLoS One. 2022;17:e0268434.
    PubMed         Abstract available

  68. KOMISSAROV A, Karaseva M, Roschina M, Kostrov S, et al
    The SARS-CoV-2 main protease doesn't induce cell death in human cells in vitro.
    PLoS One. 2022;17:e0266015.
    PubMed         Abstract available

  69. JONES H, Seaborne M, Cowley L, Odd D, et al
    Population birth outcomes in 2020 and experiences of expectant mothers during the COVID-19 pandemic: A 'born in Wales' mixed methods study using routine data.
    PLoS One. 2022;17:e0267176.
    PubMed         Abstract available

  70. KUMARI P, Pradhan B, Koromina M, Patrinos GP, et al
    Discovery of new drug indications for COVID-19: A drug repurposing approach.
    PLoS One. 2022;17:e0267095.
    PubMed         Abstract available

  71. VAN TIENOVEN TP, Glorieux A, Minnen J, Te Braak P, et al
    Graduate students locked down? PhD students' satisfaction with supervision during the first and second COVID-19 lockdown in Belgium.
    PLoS One. 2022;17:e0268923.
    PubMed         Abstract available

  72. RAQIB R, Sarker P, Akhtar E, Nurul Huda TM, et al
    Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    PLoS One. 2022;17:e0268093.
    PubMed         Abstract available

  73. GETAWA S, Aynalem M, Bayleyegn B, Adane T, et al
    Knowledge, attitude and practice towards COVID-19 among secondary school students in Gondar town, Northwest Ethiopia.
    PLoS One. 2022;17:e0268084.
    PubMed         Abstract available

  74. NG JWJ, Vaithilingam S, Nair M, Hwang LA, et al
    Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
    PLoS One. 2022;17:e0268926.
    PubMed         Abstract available

  75. KANG S, Hou X, Hu Y, Liu H, et al
    Dynamical analysis and optimal control of the developed information transmission model.
    PLoS One. 2022;17:e0268326.
    PubMed         Abstract available

  76. DAS A, Garg R, Kumar ES, Singh D, et al
    Implementation of infection prevention and control practices in an upcoming COVID-19 hospital in India: An opportunity not missed.
    PLoS One. 2022;17:e0268071.
    PubMed         Abstract available

  77. LIMA DP, Queiroz IB, Carneiro AHS, Pereira DAA, et al
    Feasibility indicators of telemedicine for patients with dementia in a public hospital in Northeast Brazil during the COVID-19 pandemic.
    PLoS One. 2022;17:e0268647.
    PubMed         Abstract available

    Symptoms of psychological distress amongst women during the COVID-19 pandemic in Saudi Arabia.
    PLoS One. 2022;17:e0268642.
    PubMed         Abstract available

  79. NISHIMURA M, Sugawa S, Ota S, Suematsu E, et al
    Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
    PLoS One. 2022;17:e0267566.
    PubMed         Abstract available

  80. PARAMASIVAN K, Subburaj R, Sharma VM, Sudarsanam N, et al
    Relationship between mobility and road traffic injuries during COVID-19 pandemic-The role of attendant factors.
    PLoS One. 2022;17:e0268190.
    PubMed         Abstract available

    Impact of the twin pandemics: COVID-19 and oil crash on Saudi exchange index.
    PLoS One. 2022;17:e0268733.
    PubMed         Abstract available

  82. KIM H, Hughes E, Cavanagh A, Norris E, et al
    The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review.
    PLoS One. 2022;17:e0268866.
    PubMed         Abstract available

  83. MURUGESAN M, Mathews P, Paul H, Karthik R, et al
    Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India.
    PLoS One. 2022;17:e0268797.
    PubMed         Abstract available

  84. CHINVARARAK C, Kerdcharoen N, Pruttithavorn W, Polruamngern N, et al
    Mental health among healthcare workers during COVID-19 pandemic in Thailand.
    PLoS One. 2022;17:e0268704.
    PubMed         Abstract available

  85. ELTAHIR ME, Alsalhi NR, Al-Qatawneh SS
    Implementation of E-exams during the COVID-19 pandemic: A quantitative study in higher education.
    PLoS One. 2022;17:e0266940.
    PubMed         Abstract available

  86. RIDENHOUR BJ, Sarathchandra D, Seamon E, Brown H, et al
    Effects of trust, risk perception, and health behavior on COVID-19 disease burden: Evidence from a multi-state US survey.
    PLoS One. 2022;17:e0268302.
    PubMed         Abstract available

  87. FERRARI E, Gargani L, Barbieri G, Ghiadoni L, et al
    A causal learning framework for the analysis and interpretation of COVID-19 clinical data.
    PLoS One. 2022;17:e0268327.
    PubMed         Abstract available

  88. BOWER M, Donohoe-Bales A, Smout S, Ngyuen AQH, et al
    In their own words: An Australian community sample's priority concerns regarding mental health in the context of COVID-19.
    PLoS One. 2022;17:e0268824.
    PubMed         Abstract available

  89. SHAW PA, Yang JB, Mowery DL, Schriver ER, et al
    Determinants of hospital outcomes for patients with COVID-19 in the University of Pennsylvania Health System.
    PLoS One. 2022;17:e0268528.
    PubMed         Abstract available

  90. FALODUN O, Medugu N, Sabir L, Jibril I, et al
    An epidemiological study on face masks and acne in a Nigerian population.
    PLoS One. 2022;17:e0268224.
    PubMed         Abstract available

  91. OSBURN WO, Smith K, Yanek L, Amat-Alcaron N, et al
    Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19.
    PLoS One. 2022;17:e0268296.
    PubMed         Abstract available

  92. AYELE TA, Shibru H, Mequanent Sisay M, Melese T, et al
    The effect of COVID-19 on poor treatment control among ambulatory Hypertensive and/or Diabetic patients in Northwest Ethiopia.
    PLoS One. 2022;17:e0266421.
    PubMed         Abstract available

  93. DAZA-TORRES ML, Garcia YE, Schmidt AJ, Pollock BH, et al
    The impact of COVID-19 vaccination on California's return to normalcy.
    PLoS One. 2022;17:e0264195.
    PubMed         Abstract available

  94. OSUJI VC, Galante EM, Mischoulon D, Slaven JE, et al
    COVID-19 vaccine: A 2021 analysis of perceptions on vaccine safety and promise in a U.S. sample.
    PLoS One. 2022;17:e0268784.
    PubMed         Abstract available

  95. BAEK KH, Jang D, Kim T, Park JY, et al
    Instant inactivation of aerosolized SARS-CoV-2 by dielectric filter discharge.
    PLoS One. 2022;17:e0268049.
    PubMed         Abstract available

  96. ABID K, Ahmed H, Bari YA, Younus M, et al
    Perceived barriers to facemask adherence in the covid-19 pandemic in Pakistan-A cross-sectional survey.
    PLoS One. 2022;17:e0267376.
    PubMed         Abstract available

  97. BONNER KE, Ssekyanzi H, Sicsic J, Mueller JE, et al
    What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.
    PLoS One. 2022;17:e0268063.
    PubMed         Abstract available

  98. ACHARYA B, Dhakal C
    Risky health behaviors during the COVID-19 pandemic: Evidence from the expenditures on alcohol, non-alcoholic beverages, and tobacco products.
    PLoS One. 2022;17:e0268068.
    PubMed         Abstract available

  99. ETTA G, Galeazzi A, Hutchings JR, James Smith CS, et al
    COVID-19 infodemic on Facebook and containment measures in Italy, United Kingdom and New Zealand.
    PLoS One. 2022;17:e0267022.
    PubMed         Abstract available

  100. GRAHAM C, Chun Y, Hamilton B, Roll S, et al
    Coping with COVID-19: Differences in hope, resilience, and mental well-being across U.S. racial groups.
    PLoS One. 2022;17:e0267583.
    PubMed         Abstract available

  101. BESLEY T, Dray S
    Pandemic responsiveness: Evidence from social distancing and lockdown policy during COVID-19.
    PLoS One. 2022;17:e0267611.
    PubMed         Abstract available

  102. WITUS LS, Larson E
    A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention.
    PLoS One. 2022;17:e0267580.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  103. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al
    Simulating COVID-19 classroom transmission on a university campus.
    Proc Natl Acad Sci U S A. 2022;119:e2116165119.
    PubMed         Abstract available

  104. MUTSCH B, Heiber M, Gratz F, Hain R, et al
    Aerosol particle emission increases exponentially above moderate exercise intensity resulting in superemission during maximal exercise.
    Proc Natl Acad Sci U S A. 2022;119:e2202521119.
    PubMed         Abstract available

  105. COMAR CE, Otter CJ, Pfannenstiel J, Doerger E, et al
    MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.
    Proc Natl Acad Sci U S A. 2022;119:e2123208119.
    PubMed         Abstract available

  106. ELTOBGY MM, Zani A, Kenney AD, Estfanous S, et al
    Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.
    Proc Natl Acad Sci U S A. 2022;119:e2202012119.
    PubMed         Abstract available

  107. HARRISON NL, Sachs JD
    A call for an independent inquiry into the origin of the SARS-CoV-2 virus.
    Proc Natl Acad Sci U S A. 2022;119:e2202769119.


  108. FOO D, Sarna M, Pereira G, Moore HC, et al
    Maternal influenza vaccination and child mortality: Longitudinal, population-based linked cohort study.
    Vaccine. 2022 May 20. pii: S0264-410X(22)00614.
    PubMed         Abstract available

  109. KITCHEN M, Leierer G, Kistner O, Wodal W, et al
    High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
    Vaccine. 2022 May 20. pii: S0264-410X(22)00575.
    PubMed         Abstract available

  110. MCELFISH PA, Selig JP, Scott AJ, Rowland B, et al
    Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans.
    Vaccine. 2022 May 20. pii: S0264-410X(22)00615.
    PubMed         Abstract available

  111. SALO-TUOMINEN K, Teros-Jaakkola T, Toivonen L, Ollila H, et al
    Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children.
    Vaccine. 2022 May 17. pii: S0264-410X(22)00582.
    PubMed         Abstract available

  112. GASTEIGER N, Gasteiger C, Vedhara K, Broadbent E, et al
    Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach.
    Vaccine. 2022 May 5. pii: S0264-410X(22)00547.
    PubMed         Abstract available

  113. BIFULCO M, Di Zazzo E, Pisanti S, Martini M, et al
    The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon?
    Vaccine. 2022 May 6. pii: S0264-410X(22)00492.
    PubMed         Abstract available

  114. BOTHUN LS, Feeder SE, Poland GA
    Readability of COVID-19 vaccine information for the general public.
    Vaccine. 2022 May 3. pii: S0264-410X(22)00546.
    PubMed         Abstract available

  115. LUMBRERAS ARETA M, Valiton A, Diana A, Morales M, et al
    Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study.
    Vaccine. 2022 May 6. pii: S0264-410X(22)00533.
    PubMed         Abstract available

  116. HUSSAIN B, Latif A, Timmons S, Nkhoma K, et al
    Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.
    Vaccine. 2022 Apr 28. pii: S0264-410X(22)00446.
    PubMed         Abstract available

    Virus Res

  117. MEISTER TL, Gottsauner JM, Schmidt B, Heinen N, et al
    Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial.
    Virus Res. 2022;316:198791.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.